Clinical trials
Completed Observational Cholangiocarcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 4 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 45 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| City of Hope Medical Center | 3 |
| Al-Azhar University | 1 |
| Alaunos Therapeutics | 1 |
| ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Azienda Unita Sanitaria Locale di Piacenza | 1 |
| Boston Scientific Corporation | 1 |
| CHA University | 1 |
| CHU de Reims | 1 |
| Centre Hospitalier Universitaire, Amiens | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 45 |
| Carcinoma, Hepatocellular | 12 |
| Pancreatic Neoplasms | 11 |
| Liver Neoplasms | 9 |
| Breast Neoplasms | 4 |
| Klatskin Tumor | 4 |
| Neoplasm Metastasis | 4 |
| Adenocarcinoma | 3 |
| Bile Duct Neoplasms | 3 |
| Carcinoma, Renal Cell | 3 |
Trials
Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.